Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medtronic Investors with Significant Losses are Encouraged to Contact Deans & Lyons LLP Securities Lawyers

MDT
Medtronic Investors with Significant Losses are Encouraged to Contact Deans & Lyons LLP Securities Lawyers

DALLAS, July 18, 2013 /PRNewswire/ -- Deans & Lyons announced a class action against Medtronic, Inc. (NYSE: MDT).  MDT investors who purchased between December 8, 2010 and August 3, 2011 are encouraged to contact securities attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies by August 26, 2013.

"According the complaint, certain officers and directors at Medtronic issued misleading and/or false information regarding the product Infuse," said securities lawyer Hamilton Lindley. "Prices of MDT stock were artificially inflated as a result of the possible false statements." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com
www.deanslyons.com

SOURCE Deans & Lyons LLP



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today